Mucolytic Solution Before Upper Endoscopy

NCT02967094 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2016-11-29

No results posted yet for this study

Summary

Study was designed to evaluate efficacy of mucolytic solution ingested before upper endoscopy on visibility of gastric mucosa.

Conditions

  • Gastroscopy; Gastric Cancer

Interventions

DRUG

Administration of mucolytic solution before upper endoscopy (Espumisan, ACC long)

DRUG

Administration of water before upper endoscopy

Sponsors & Collaborators

  • Vitkovice Hospital

    lead OTHER

Principal Investigators

  • Premysl Falt, M.D., Ph.D. · Digestive Diseases Center, Vítkovice Hospital

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02967094 on ClinicalTrials.gov